BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Leqembi (lecanemab) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...
Nelnet Campus Commerce, a leader in higher education payment technology, is pleased to announce that it processed more than 230,000 automated clearing house (ACH) refunds totaling over $602 million, ...
Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.
Diamond Hill Investment Group, Inc. (Nasdaq: DHIL) today reported unaudited financial results for the third quarter of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback